MYX 2.67% $4.62 mayne pharma group limited

Mayne Pharma sees strong sales growth in FY 2023, page-48

  1. 7,138 Posts.
    lightbulb Created with Sketch. 546
    To gain confidence from investors you need deliver your outlook, at least ONCE.
    So far Mayne Pharma has missed every single promise it made.
 
watchlist Created with Sketch. Add MYX (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.